Related Experiment Videos
[Rheumatoid polyarthritis: therapeutic management]
1Fédération de Rhumatologie, Hôpital Lapeyronie, CHU de Montpellier. combe@u291.montp.inserm.fr
Presse Medicale (Paris, France : 1983)
|January 20, 1999
Summary
Early rheumatoid arthritis treatment is crucial and should be individualized. For long-standing disease, combination regimens are recommended, while remission requires sustained treatment.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Background:
- Rheumatoid arthritis (RA) management is complex and debated.
- Early treatment initiation is vital to limit disease progression.
- Understanding predictive factors for RA severity is advancing.
Purpose of the Study:
- To outline current therapeutic strategies for rheumatoid arthritis.
- To emphasize individualized treatment approaches for early RA.
- To address treatment considerations for patients in remission and with long-standing disease.
Main Methods:
- Review of recent clinical trial findings.
- Analysis of factors influencing treatment decisions in early RA.
- Discussion of treatment discontinuation criteria and long-standing RA management.
Main Results:
- Initiating treatment at disease onset is confirmed as important for all RA patients.
- Individualized regimens for early RA should consider drug risks/benefits and inflammation.
- Sustained treatment is recommended for patients in remission; progressive discontinuation only after prolonged remission.
Conclusions:
- Therapeutic strategies for RA require careful consideration of disease stage.
- Individualized treatment plans are essential for early RA.
- Optimal management for long-standing RA likely involves full-dose combination regimens.